Last reviewed · How we verify
KH001
At a glance
| Generic name | KH001 |
|---|---|
| Sponsor | Byoung-Moo Seo |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE) (PHASE2)
- A Study to Evaluate Physiologic Dentin Regeneration and Safety of KH001 in the Administration of Erupted Wisdom Tooth With Dentin Caries (PHASE2)
- Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity (PHASE2)
- A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity (PHASE2)
- Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KH001 CI brief — competitive landscape report
- KH001 updates RSS · CI watch RSS
- Byoung-Moo Seo portfolio CI